In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Naiyer Rizvi argues in favor of single drug therapy for targeting the immune system with checkpoint inhibitors.
Earn CME Credit for a related activity: http://elc.imedex.com/ELC/Specialty-Search.aspx?search=Lung
© 2017 Imedex, LLC.
Advertisement